U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Chronic Lymphocytic Leukemia

MedGen UID:
167714
•Concept ID:
C0854802
•
Neoplastic Process
Synonyms: Chronic Lymphocytic Leukemia Recurrent; Chronic lymphoid leukemia in relapse; Recurrent B-Cell Chronic Lymphocytic Leukemia; Recurrent Chronic Lymphoid Leukemia; Relapsed Chronic Lymphocytic Leukemia; Relapsed Chronic Lymphoid Leukemia
SNOMED CT: Chronic lymphoid leukemia in relapse (122961000119105)

Definition

The reemergence of chronic lymphocytic leukemia after a period of remission. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent Chronic Lymphocytic Leukemia

Professional guidelines

PubMed

The combination of venetoclax and rituximab for the treatment of patients with recurrent chronic lymphocytic leukemia.
Vitale C, Ferrajoli A
Expert Rev Hematol 2020 Aug;13(8):885-894. Epub 2020 Jul 26 doi: 10.1080/17474086.2020.1796620. PMID: 32700593

Recent clinical studies

Etiology

Secondary cervical cancer in a patient with chronic lymphocytic leukemia and recurrent chronic lymphocytic leukemia mimicking recurrent cervical dysplasia: a case report.
Magley J, Moyers C, Ballard KS, Tedjarati S
J Reprod Med 2010 Mar-Apr;55(3-4):175-8. PMID: 20506683

Diagnosis

The combination of venetoclax and rituximab for the treatment of patients with recurrent chronic lymphocytic leukemia.
Vitale C, Ferrajoli A
Expert Rev Hematol 2020 Aug;13(8):885-894. Epub 2020 Jul 26 doi: 10.1080/17474086.2020.1796620. PMID: 32700593
Secondary cervical cancer in a patient with chronic lymphocytic leukemia and recurrent chronic lymphocytic leukemia mimicking recurrent cervical dysplasia: a case report.
Magley J, Moyers C, Ballard KS, Tedjarati S
J Reprod Med 2010 Mar-Apr;55(3-4):175-8. PMID: 20506683

Therapy

Assessing the transition from intravenous to subcutaneous delivery of rituximab: Benefits for payers, health care professionals, and patients with lymphoma.
Harvey MJ, Zhong Y, Morris E, Beverage JN, Epstein RS, Chawla AJ
PLoS One 2022;17(1):e0261336. Epub 2022 Jan 24 doi: 10.1371/journal.pone.0261336. PMID: 35073335Free PMC Article
The combination of venetoclax and rituximab for the treatment of patients with recurrent chronic lymphocytic leukemia.
Vitale C, Ferrajoli A
Expert Rev Hematol 2020 Aug;13(8):885-894. Epub 2020 Jul 26 doi: 10.1080/17474086.2020.1796620. PMID: 32700593

Prognosis

The combination of venetoclax and rituximab for the treatment of patients with recurrent chronic lymphocytic leukemia.
Vitale C, Ferrajoli A
Expert Rev Hematol 2020 Aug;13(8):885-894. Epub 2020 Jul 26 doi: 10.1080/17474086.2020.1796620. PMID: 32700593

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...